Samuel D Isaly's Net Worth

$1.14 Billion

Who is Samuel D Isaly?

Samuel D Isaly has an estimated net worth of $1.14 Billion. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., COMPLETE GENOMICS INC, INSULET CORP, Volcano Corp, AMARIN CORP PLC\UK, Relypsa Inc, ChemoCentryx, Inc., Mirati Therapeutics, Inc., GLAUKOS Corp, INTERCEPT PHARMACEUTICALS INC, Intellia Therapeutics, Inc., ALPINE IMMUNE SCIENCES, INC., SUPERNUS PHARMACEUTICALS INC, PIERIS PHARMACEUTICALS, INC., ViewRay, Inc., CTI BIOPHARMA CORP, Aadi Bioscience, Inc., ProNAi Therapeutics Inc, Adaptimmune Therapeutics PLC, Pacira Pharmaceuticals, Inc., Loxo Oncology, Inc., Sientra, Inc., SELECTA BIOSCIENCES INC, Nabriva Therapeutics AG, Xtant Medical Holdings, Inc., Dimension Therapeutics, Inc., Aeglea BioTherapeutics, Inc., Kala Pharmaceuticals, Inc., scPharmaceuticals Inc., SteadyMed Ltd., SYNLOGIC, INC., OTONOMY, INC., Arsanis, Inc., RESPONSE BIOMEDICAL CORP, AVANIR PHARMACEUTICALS, Roka BioScience, Inc., Audentes Therapeutics, Inc., Biodel Inc, AMBIT BIOSCIENCES CORP, Anthera Pharmaceuticals Inc, NxStage Medical, Inc., ACCELERON PHARMA INC, MEMORY PHARMACEUTICALS CORP, ORPHAN MEDICAL INC, Kun Run Biotechnology, Inc., ARYx Therapeutics, Inc., CRYOCOR INC, AEROGEN INC, ATHERSYS, INC / NEW, Corvus Pharmaceuticals, Inc., ORCHID BIOSCIENCES INC, GIVEN IMAGING LTD, LIFECELL CORP, and DOV PHARMACEUTICAL INC.

SEC CIK

Samuel D Isaly's CIK is 0001055949

Past Insider Trading and Trends

2017 was Samuel D Isaly's most active year for acquiring shares with 54 total transactions. Samuel D Isaly's most active month to acquire stocks was the month of April. 2015 was Samuel D Isaly's most active year for disposing of shares, totalling 98 transactions. Samuel D Isaly's most active month to dispose stocks was the month of February. 2016 saw Samuel D Isaly paying a total of $43,188,607.10 for 16,042,108 shares, this is the most they've acquired in one year. In 2016 Samuel D Isaly cashed out on 16,577,014 shares for a total of $164,332,587.98, their largest year based on trade value.